- Works count
- 749
- Citation count
- 12,830
- H-index
- 53
- i10-index
- 181
Research interests
Publications
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2401726
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer
Journal of Clinical Oncology · 2023 · https://doi.org/10.1200/jco.22.02887
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer
Journal of Clinical Oncology · 2022 · https://doi.org/10.1200/jco.22.01643
CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor
Immunity · 2022 · https://doi.org/10.1016/j.immuni.2022.12.002
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial
The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)00581-x
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(21)00241-2
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.02.024
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)31187-9
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study
The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(18)30907-0
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
Nature · 2019 · https://doi.org/10.1038/s41586-019-1836-5
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapy
Cancer · 2018 · https://doi.org/10.1002/cncr.31778
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience
Investigational New Drugs · 2017 · https://doi.org/10.1007/s10637-017-0534-0
Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology
CA A Cancer Journal for Clinicians · 2017 · https://doi.org/10.3322/caac.21406
BMP4 Promotes Prostate Tumor Growth in Bone through Osteogenesis
Cancer Research · 2011 · https://doi.org/10.1158/0008-5472.can-10-4374
Cadherin-11 Increases Migration and Invasion of Prostate Cancer Cells and Enhances their Interaction with Osteoblasts
Cancer Research · 2010 · https://doi.org/10.1158/0008-5472.can-09-3016
Current projects
No projects listed.